Quality of Erection Study

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

January 31, 2006

Conditions
Erectile Dysfunction
Interventions
DRUG

Sildenafil Citrate

Trial Locations (23)

16070

Pfizer Investigational Site, Bursa

21280

Pfizer Investigational Site, Diyarbakır

34900

Pfizer Investigational Site, Istanbul

35039

Pfizer Investigational Site, Marburg

35100

Pfizer Investigational Site, Izmir

50139

Pfizer Investigational Site, Florence

65929

Pfizer Investigational Site, Frankfurt

81369

Pfizer Investigational Site, München

81925

Pfizer Investigational Site, München

82319

Pfizer Investigational Site, Starnberg

95124

Pfizer Investigational Site, Catania

30130-008

Pfizer Investigational Site, Belo Horizonte

20551-030

Pfizer Investigational Site, Rio de Janeiro

13500-020

Pfizer Investigational Site, Rio Claro

04044-060

Pfizer Investigational Site, São Paulo

04262-000

Pfizer Investigational Site, São Paulo

D 83022

Pfizer Investigational Site, Rosenheim

00161

Pfizer Investigational Site, Roma

90-625

Pfizer Investigational Site, Lodz

93-171

Pfizer Investigational Site, Lodz

20-008

Pfizer Investigational Site, Lublin

71-240

Pfizer Investigational Site, Szczecin

00-911

Pfizer Investigational Site, Warsaw

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00159900 - Quality of Erection Study | Biotech Hunter | Biotech Hunter